H.C. Wainwright & Co.
Aegis Capital Corp.
Dawson James Securities
Maxim Group
Kintara Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Kintara Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Kintara Therapeutics, Inc. or its management. Kintara Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.